Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
BeOne Medicines
Chordia Therapeutics, Inc.
GluBio Therapeutics Inc.
Beijing InnoCare Pharma Tech Co., Ltd.
TScan Therapeutics, Inc.
Bristol-Myers Squibb
Seagen Inc.
Taiho Oncology, Inc.
Remedy Plan, Inc.
Sumitomo Pharma America, Inc.
AstraZeneca
Swedish Orphan Biovitrum
Takeda
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Disc Medicine, Inc
Orca Biosystems, Inc.
Cullinan Therapeutics Inc.
MacroGenics
medac GmbH
Celgene
Massive Bio, Inc.
Rigel Pharmaceuticals
Ellipses Pharma
BlossomHill Therapeutics
Ossium Health, Inc.
Hangzhou GluBio Pharmaceutical Co., Ltd.
Servier
Remix Therapeutics
Tr1X, Inc.
NovaOnco Therapeutics Co., Ltd.
Advanced BioDesign
Ascentage Pharma Group Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Shenzhen TargetRx Co., Ltd.
Edgewood Oncology Inc.
Celyad Oncology SA